ProCE Banner Activity

Phase II CALGB 50604: Choosing Chemo/Radiotherapy by PET Status in Hodgkin’s Lymphoma

Slideset Download
Conference Coverage
Use of interim PET allows more patients to avoid IFRT while still achieving 3-year PFS.

Released: December 12, 2015

Expiration: December 10, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen